Modulation of Toll Like Receptor-2 on sebaceous gland by the treatment of adult female acne

References

• Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474-85. https://doi.org/10.1111/bjd.12149
   PubMed Web of Science ®Google Scholar
• Albuquerque RG, Rocha MA, Bagatin E, Tufik S, Andersen ML. Could adult female acne be associated with modern life? Arch Dermatol Res. 2014;306(8):683-8. https://doi.org/10.1007/s00403-014-1482-6
   PubMed Web of Science ®Google Scholar
• Collier CN, Harper JC, Cafardi JA, Wang W, Foster KW. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58:56-9. https://doi.org/10.1016/j.jaad.2007.06.045.
   PubMed Web of Science ®Google Scholar
• Kim GK, Michaels BB. Post-adolescent acne in women: more common and more clinical considerations. J Drugs Dermatol. 2012;11(6):708-13
   PubMed Web of Science ®Google Scholar
• Willians C, Layton AM. Persistent acne in women. Am J Clin Dermatol. 2006;7(5):281-90. https://doi.org/10.2165/00128071-200607050-00002
   PubMed Web of Science ®Google Scholar
• Dumont-Wallon G, Dreno B. Specificity of acne in women older than 25 years. Presse Med. 2008;37(pt1):585-91. https://doi.org/10.1016/j.lpm.2007.07.014
   PubMed Web of Science ®Google Scholar
• Preneau S, Dreno B. Female acne – a different subtype of teenager acne? J Eur Acad Dermatol Venereol. 2012;26(3):277-82. https://doi.org/10.1111/j.1468-3083.2011.04214.x
   PubMed Web of Science ®Google Scholar
• Dreno B, Layton A, Zouboulis CC, López-Estebaranz JL, Zalewska-Janowska A, Bagatin E, Zampeli VA, Yutskovskaya Y, Harper JC. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol. 2013;27(9):1063-70. https://doi.org/10.1111/jdv.12061
   PubMed Web of Science ®Google Scholar
• Dreno B, Thiboutot D, Layton AM, Berson D, Perez M, Kang S. On behalf of the Global Alliance to Improve Outcomes in Acne. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015;29:1096-106. https://doi.org/10.1111/jdv.12757
   PubMed Web of Science ®Google Scholar
• Zeichner JA, Baldwin HE, Cook-Bolden FE, Eichenfield LF, Fallon-Friedlander S, Rodriguez DA. Emerging Issues in Adult Female Acne. J Clin Aesthet Dermatol. 2017;10(1):37-46.
   PubMedGoogle Scholar
• Holzmann R, Shakery K. Postadolescent Acne in Females. Skin Pharmacol Physiol. 2014;27(suppl 1):3-8. https://doi.org/10.1159/000354887
   PubMed Web of Science ®Google Scholar
• Tanghetti EA. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 2013;6(9):27-35.
   PubMedGoogle Scholar
• Rocha MA, Costa CS, Bagatin E. Acne vulgaris: an inflammatory disease even before the onset of clinical lesions. Inflamm Allergy Drug Targets. 2014;13(3):162-7. https://doi.org/10.2174/1871528113666140606110024
   PubMedGoogle Scholar
• Kurokawa I, Danby WJ, Ju Q, Wang X, Xiang LF, Xia L, Chen W, Nagy I, Picardo M, Suh DH, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18:821-32. https://doi.org/10.1111/j.1600-0625.2009.00890.x
   PubMed Web of Science ®Google Scholar
• Lancaster IG, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, Drayson MT, Gleeson M. The physiological regulation of toll-like receptor expression and function in humans. J Physiol. 2005;563(3):945-55. https://doi.org/10.1113/jphysiol.2004.081224
   PubMed Web of Science ®Google Scholar
• McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol. 2005;125(1):1-8. https://doi.org/10.1111/j.0022-202X.2004.23459.x
   PubMed Web of Science ®Google Scholar
• Zouboulis CC. Sebaceous gland receptors. Dermato-Endocrinol. 2009;1(2):77-80. https://doi.org/10.4161/derm.1.2.7804
   PubMedGoogle Scholar
• Pivarcsi A, Koreck A, Bodai L, Szell M, Szeg C, Belso N, Kenderessy-Szabo A, Bata-Csorgo Z, Dobozy A, Kemeny L. Differentiation-regulated expression of Toll-like receptors 2 and 4 in HaCaT keratinocytes. Arch Dermatol Res. 2004;296:120-4. https://doi.org/10.1007/s00403-004-0475-2
   PubMed Web of Science ®Google Scholar
• Fathy A, Mohamed RW, Ismael NA, El-Akhras MA. Expression of toll-like receptors on peripheral monocytes of patients with inflammatory and noninflammatoy acne vulgaris. Egypt J Immunol. 2009;16(1):127-34.
   PubMedGoogle Scholar
• Kim J. Review of the innate response in acne vulgaris: activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211:193-98. https://doi.org/10.1159/000087011
   PubMed Web of Science ®Google Scholar
• Selway JL, Kurczab T, Kealey T, Langlands K. Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne. BMC Dermatology. 2013;13:10. https://doi.org/10.1186/1471-5945-13-10
   PubMedGoogle Scholar
• Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, Dreno B. Induction of toll-like receptor by Propionibacterium acnes. Br J Dermatol. 2005;153(6):1105-13. https://doi.org/10.1111/j.1365-2133.2005.06933.x
   PubMed Web of Science ®Google Scholar
• Tenaud I, Khammari A, Dréno B. In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol. 2007;16:500-6. https://doi.org/10.1111/j.1600-0625.2007.00552.x
   PubMed Web of Science ®Google Scholar
• Bakry OA, Samaka RM, Sebika H. Toll-lke receptor 2 and P. acnes: Do They trigger initial acne vulgaris lesions? Anal Quant Cytopathol Histpathol. 2014;36(2):100-10.
   PubMed Web of Science ®Google Scholar
• Taylor M, Gonzalez M, Porter R. Pathways to inflammation: acne pathophysiology. Eur J Dermatol. 2011;21(3):323-33.
   PubMed Web of Science ®Google Scholar
• Vera N, Patel N, Cardwell LA, Saleem M, Feldman SR. Chemical pharmacotherapy options for managing adult acne. Expert Opin Pharmacotherapy. 2017;18(3):263. https://doi.org/10.1080/14656566.2017.1282460
   PubMed Web of Science ®Google Scholar
• Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? Facts and controversies. Clin Dermatol. 2010;28(1):17-23. https://doi.org/10.1016/j.clindermatol.2009.03.006
   PubMed Web of Science ®Google Scholar
• Lakshmi C. Hormonal Therapy in acne. Indian J Dermatol Venereol Leprol. 2013;79:322-37. https://doi.org/10.4103/0378-6323.110765
   PubMed Web of Science ®Google Scholar
• Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J. A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment. Cutis. 2008;82(2):143-50.
   PubMed Web of Science ®Google Scholar
• Maloney JM, Dietze P Jr, Watson D, Niknian M, Lee-Rugh S, Sampson-Landers C, Korner P. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial. Obstet Gynecol. 2008;112(4):773-81. https://doi.org/10.1097/AOG.0b013e318187e1c5
   PubMed Web of Science ®Google Scholar
• Tyler KH, Zirwas MJ. Contraception and the dermatologist. J Am Acad Dermatol. 2013;68(6):1022-9. https://doi.org/10.1016/j.jaad.2012.11.018
   PubMed Web of Science ®Google Scholar
• Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;7. Art. No.: CD004425. https://doi.org/10.1002/14651858.CD004425.pub5
   Web of Science ®Google Scholar
• Raymond EG, Burke AE, Espey E. Combined hormonal contraceptives and venous tromboembolism: putting the risks into perspective. Obstet Gynecol. 2012;119:1039-44. https://doi.org/10.1097/AOG.0b013e31825194ca
   PubMed Web of Science ®Google Scholar
• Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous tromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697-706. https://doi.org/10.7326/0003-4819-143-10-200511150-00006
   PubMed Web of Science ®Google Scholar
• Thiboutot D. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol. 2008;7(1):13-6.
   PubMed Web of Science ®Google Scholar
• Bagatin E, Holzmann R, Shakery K, Sieber MA, Hegel JKE, Vargas-Diez E, Hofmann MA, Bravo B, Malgazhdarovag KAO, Yutzcovskaya Y. Adult female acne. Azelaic acid in the treatment of acne in adult female. Skin Pharmacol Physiol. 2014;27(Suppl 1):1-2. https://doi.org/10.1159/000354886
   PubMed Web of Science ®Google Scholar
• Mastrofrancesco A, Ottaviani M, Aspite N, Cardinali G, Izzo E, Graupe K, Zouboulis CC, Camera E, Picardo M. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPAR gamma activation. Exp Dermatol. 2010;19(9):813-20. https://doi.org/10.1111/j.1600-0625.2010.01107.x
   PubMed Web of Science ®Google Scholar
• Briganti S, Flori E, Mastrofrancesco A, Kovacs D, Camera E, Ludovici M, Cardinali G, Picardo M. Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARγ. Exp Dermatol. 2013;22(1):41-7. https://doi.org/10.1111/exd.12066
   PubMed Web of Science ®Google Scholar
• Thielitz A, Lux A, Wiede A, Kropf S, Papakonstantinou E, Gollnick H. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne. J Eur Acad Dermatol Venereol. 2015;29(4):789-96. https://doi.org/10.1111/jdv.12823
   PubMed Web of Science ®Google Scholar
• Choi CW, Lee DH, Kim HS, Kim BY, Park KC, Youn SW. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol. 2011;25(4):454-61. https://doi.org/10.1111/j.1468-3083.2010.03813.x
   PubMed Web of Science ®Google Scholar
• Capitanio B, Sinagra JL, Bordignon V, Cordiali Fei P, Picardo M, Zouboulis CC. Understimated clinical features of postadolescent acne. J Am Acad Dermatol. 2010;63:782-8. https://doi.org/10.1016/j.jaad.2009.11.021
   PubMed Web of Science ®Google Scholar
• Dispenza MC, Wolpert EB, Gilliland KL, Dai JP, Cong Z, Nelson AM, Thiboutot DM. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol. 2012;132(9):2198-205. https://doi.org/10.1038/jid.2012.111
   PubMed Web of Science ®Google Scholar
• Auffret N, P. Claudel J-P, Leccia M-T, Poli F, Farhi D, B. Dreno B. AFAST – Adult Female Acne Scoring Tool: an easy-to-use tool for scoring acne in adult females. J Eur Acad Dermatol Venereol. 2016;30:824-8. https://doi.org/10.1111/jdv.13518
   PubMed Web of Science ®Google Scholar
• Albuquerque RG, Rocha MAD, Hirotsu C, Hachul H, Bagatin E, Tufik S, Andersen ML. A randomized comparative trial of a combined oral contraceptive and azelaic acid to assess their effect on sleep quality in adult female acne patients. Arch Dermatol Res. 2015;307(10):905-915. https://doi.org/10.1007/s00403-015-1600-0
   PubMed Web of Science ®Google Scholar
• Zaenglein AL, Pathy AL, Bethanee J., Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, Bowe WP, Graber EM, MD, Harper JC, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945-73. https://doi.org/10.1016/j.jaad.2015.12.037
   PubMed Web of Science ®Google Scholar
• Su Q, Grabowski M, Weindl G. Recognition of Propionibacterium acnes by human TLR2 heterodimers. Int J Med Microbiol. 2017;307(2):108-12. https://doi.org/10.1016/j.ijmm.2016.12.002
   PubMed Web of Science ®Google Scholar
• Ozlu E, Karadag AS, Ozkanli S, Oguztuzun S, Kilic M, Zemheri E, Akbulak O, Akdeniz N. Comparison of TLR-2, TLR-4, and antimicrobial peptide levels in different lesions of acne vulgaris. Cutan Ocul Toxicol. 2016 Dec;35(4):300-9. https://doi.org/10.3109/15569527.2015.1120742
   PubMed Web of Science ®Google Scholar
• Thiboutot DM, Layton AM, Eady EA. IL-17: a key player in the P. acnes inflammatory cascade? J Invest Dermatol. 2014;134(2):307-10. https://doi.org/10.1038/jid.2013.400
   PubMed Web of Science ®Google Scholar